| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Ra Capital Management LP | Director | 2026-03-30 | 971,091 | $6.50 | $6.31MBuy |
| Ra Capital Management LP | Director | 2026-03-27 | 2,495,623 | $6.43 | $16.05MBuy |
| Ra Capital Management LP | Director | 2026-03-26 | 351,224 | $6.38 | $2.24MBuy |
| Ra Capital Management LP | Director | 2026-03-26 | 4,954,558 | $6.06 | $30.02MBuy |
| Chris Francis | SVP Corporate Development Head of Emerging Areas | 2026-02-26 | 15,294 | $4.75 | $72.65kBuy |
| Chris Francis | SVP Corporate Development Head of Emerging Areas | 2026-02-26 | 15,294 | $15.00 | $229.41kSell |
| Chris Francis | SVP Corporate Development Head of Emerging Areas | 2026-02-26 | 17,900 | $3.87 | $69.27kBuy |
| Chris Francis | SVP Corporate Development Head of Emerging Areas | 2026-02-26 | 17,900 | $15.09 | $270.18kSell |
| Paul Bolno | President and CEO | 2026-02-09 | 10,480 | $13.45 | $140.96kSell |
| Chris Francis | SVP Corporate Development Head of Emerging Areas | 2026-02-09 | 1,883 | $13.45 | $25.33kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Gsk PLC | 15.37% | 28,929,452 | $216.68M | Insider |
| Gsk PLC | 9.69% | 18,245,691 | $136.66M | Institution |
| Ra Capital Management LP | 9.67% | 18,203,009 | $136.34M | Institution |
| Fmr LLC | 8.04% | 15,135,983 | $113.37M | Institution |
| Blackrock Inc | 6.72% | 12,648,907 | $94.74M | Institution |
| Adage Capital Partners GP LLC | 5.20% | 9,786,061 | $73.30M | Institution |
| Ken Takanashi | 5.12% | 9,630,351 | $72.13M | Insider |
| Maverick Capital Ltd | 4.93% | 9,280,237 | $69.51M | Institution |
| Ra Capital Management LP | 4.04% | 7,602,428 | $56.94M | Insider |
| Price T Rowe Associates Inc | 3.93% | 7,407,372 | $55.48M | Institution |